These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7534323)

  • 1. Granulocyte colony stimulating factor (G-CSF) combined with alpha-interferon for the treatment of liver allograft recipients with viral hepatitis.
    Wright HI; Gavaler JS; Baddour N; Van Thiel DH
    J Hepatol; 1994 Nov; 21(5):915-6. PubMed ID: 7534323
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin.
    Gopal DV; Rabkin JM; Berk BS; Corless CL; Chou S; Olyaei A; Orloff SL; Rosen HR
    Liver Transpl; 2001 Mar; 7(3):181-90. PubMed ID: 11244158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allograft dysfunction and hyperbilirubinemia in a liver transplant recipient.
    Abraczinskas DR; Chung RT
    Transpl Infect Dis; 2000 Dec; 2(4):186-93. PubMed ID: 11429030
    [No Abstract]   [Full Text] [Related]  

  • 4. Preliminary experience with alpha-2b-interferon therapy of viral hepatitis in liver allograft recipients.
    Wright HI; Gavaler JS; Van Theil DH
    Transplantation; 1992 Jan; 53(1):121-4. PubMed ID: 1733058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of granulocyte colony-stimulating factor after liver transplantation.
    Foster PF; Mital D; Sankary HN; McChesney LP; Marcon J; Koukoulis G; Kociss K; Leurgans S; Whiting JF; Williams JW
    Transplantation; 1995 Jun; 59(11):1557-63. PubMed ID: 7539958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is treatment with interferon-alpha in renal transplant recipients still justified?
    Pohanka E; Kovarik J
    Nephrol Dial Transplant; 1996 Jun; 11(6):1191-2. PubMed ID: 8672000
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment induced leucopenia in hepatitis C and Role of G-CSF in its management.
    Shafi MS; Sheikh NI; Rizvi F; Afzal M; Manzoor S
    J Coll Physicians Surg Pak; 2009 Jun; 19(6):346-9. PubMed ID: 19486571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of interferon for the treatment of viral hepatitis in pediatric liver transplant recipients.
    Nour B; Tzakis A; Van Thiel DH
    J Okla State Med Assoc; 1995 Mar; 88(3):109-13. PubMed ID: 7760205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defective synthesis of granulocyte-colony stimulating factor in pegylated interferon-alpha treated chronic hepatitis C patients with declining leukocyte counts.
    Durante-Mangoni E; Iardino P; Utili R; Adinolfi LE; Ruggiero G
    Antivir Ther; 2006; 11(5):637-40. PubMed ID: 16964833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of granulocyte colony stimulating factor after liver transplantation leads to an increased incidence and severity of ischemic biliary lesions in the rat model.
    Dirsch O; Chi H; Ji Y; Gu YL; Broelsch CE; Dahmen U
    World J Gastroenterol; 2006 Aug; 12(31):5021-7. PubMed ID: 16937499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial.
    Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of granulocyte colony-stimulating factor for neutropenia after orthotopic liver transplantation: report of two cases.
    Atici AE; Bostanci EB; Ozer I; Ulas M; Akdogan M; Akoglu M
    Transplant Proc; 2011 Apr; 43(3):909-11. PubMed ID: 21486626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon alfa-2b alone or combined with recombinant granulocyte-macrophage colony-stimulating factor as treatment of chronic hepatitis C.
    Grønbaek K; Krarup HB; Ring-Larsen H; Schaffalitzky de Muckadell O; Møller A; Schlichting P; Vyberg M
    Scand J Gastroenterol; 2002 Jul; 37(7):840-4. PubMed ID: 12190100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colony-stimulating factors and coxackievirus B3 myocarditis in mice: macrophage colony-stimulating factor suppresses acute myocarditis with increasing interferon-alpha.
    Hiraoka Y; Kishimoto C; Takada H; Suzaki N; Shiraki K
    Am Heart J; 1995 Dec; 130(6):1259-64. PubMed ID: 7484779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor for hepatitis C therapy-associated neutropenia: systematic review and economic evaluation.
    Tandon P; Doucette K; Fassbender K; Vandermeer B; Durec T; Dryden DM
    J Viral Hepat; 2011 Jul; 18(7):e381-93. PubMed ID: 21692951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-α suppressed granulocyte colony stimulating factor production is reversed by CL097, a TLR7/8 agonist.
    Tajuddin T; Ryan EJ; Norris S; Hegarty JE; O'Farrelly C
    J Gastroenterol Hepatol; 2010 Dec; 25(12):1883-90. PubMed ID: 21092001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of granulocyte colony-stimulating factor on neutropenia in liver transplant recipients with hypersplenism.
    Ishizone S; Makuuchi M; Kawasaki S; Matsunami H; Terada M; Kitahara S; Kamada N; Nakahata T; Kawarasaki H; Iwanaka T
    J Pediatr Surg; 1994 Apr; 29(4):510-3. PubMed ID: 7516966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of heart allograft acceptability associated with recruitment of CD4+CD25+ T cells in peripheral blood by recipient treatment with granulocyte colony-stimulating factor.
    Liang HL; Yi DH; Zheng QJ; Du JF; Cao YX; Yu SQ; Zhu HL
    Transplant Proc; 2008 Jun; 40(5):1604-11. PubMed ID: 18589159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis?
    Berardi S; Lodato F; Gramenzi A; D'Errico A; Lenzi M; Bontadini A; Morelli MC; Tamè MR; Piscaglia F; Biselli M; Sama C; Mazzella G; Pinna AD; Grazi G; Bernardi M; Andreone P
    Gut; 2007 Feb; 56(2):237-42. PubMed ID: 16798778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-alpha inhibits CFU-GM mobilization following chemotherapy and G-CSF administration.
    Ballarino P; Castello G; Lerza R; Cerruti A; Arboscello E; Mencoboni M; Bogliolo G; Pannacciulli I
    J Interferon Cytokine Res; 1996 Nov; 16(11):953-6. PubMed ID: 8938572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.